Bio-Techne Corp's current price is $55.21, showing a recent increase of 2.56%, yet its P/E ratio stands at an inflated 109.11, indicating overvaluation, especially given a concerning EPS growth of -48.40% year-over-year. Furthermore, with a revenue growth of only 1.64% and a current ratio of 4.54, the company's financial health appears stable but lacks momentum, suggesting potential headwinds ahead.